Core Viewpoint - Zhen'an Technology (300767.SZ) announced a private placement plan to raise up to 741 million yuan, primarily to enhance liquidity and repay bank loans amid ongoing financial struggles [1] Group 1: Private Placement Details - The company plans to issue no more than 46.42 million shares at a price of 15.96 yuan per share [1] - The issuance will be directed towards actual controller Ning Huaxiang and his controlled entity Dongchuang Shuzhi, with each subscribing for no more than 23.21 million shares [1] - The shares will have a lock-up period of 18 months [1] Group 2: Financial Performance - The company's revenue is projected to decline from 694 million yuan in 2023 to 417 million yuan in 2024, with consecutive net losses of 41.13 million yuan and 141 million yuan [1] - The forecast for 2025 indicates an expanded loss of between 103 million yuan and 134 million yuan [1] - Cumulative credit impairment losses from 2022 to September 2025 exceed 220 million yuan [1] Group 3: Asset Management and Investment Issues - The company plans to recognize a fixed asset impairment of 16.5 million yuan in 2024, with further impairments anticipated due to low capacity utilization at its Hebei subsidiary [1] - The Hebei production base project, funded by a 280 million yuan convertible bond in 2021, has only seen an actual investment of 225 million yuan by September 2025, with a capacity utilization rate of only 13.3% and cumulative losses of 11.63 million yuan [1] - A previous fundraising of 245 million yuan in 2022 for a research center project was halted due to incomplete land procedures, with only the damper project commencing production by September 2025 but failing to generate benefits [1]

Group 1 - The chemical sector has shown strong performance recently, with notable gains in dispersed dyes, pesticides, and large-scale refining [1] - Jihua Group has experienced a significant rise, achieving four consecutive trading limits within five days [1] - Other companies such as Sanfangxiang, Baichuan Co., Vinegar Chemical, and Hualitai have also reached trading limits, while Hongyang, Rongsheng Petrochemical, Shandong Haohua, and Xinjiang Tianye have seen follow-up gains [1] Group 2 - Zhejiang Longsheng has announced a price increase for certain types of dispersed dyes, with a reported rise of 5,000 yuan per ton as of February 8 [1] - Additionally, starting from April 1, 2026, 94 pesticide varieties, including glufosinate-ammonium, will benefit from an export tax rebate on value-added tax [1]

2月11日，三大指数集体低开。截至发稿，国证航天航空行业指数(CN5082.SZ)跌0.3%，成分股中，华 力创通涨超1%，航天电子、振芯科技、中无人机等个股涨幅居前。 相关ETF方面，航空航天ETF天弘（159241）盘中实时成交额262万元，溢折率0.08%。资金流向方面， Wind显示，截至2月10日，该ETF近20日累计"吸金"近1.4亿元；今年以来，该ETF份额已增超48%。 航空航天ETF天弘（159241）跟踪的国证航天指数精准覆盖了空天产业链。其中，航空装备与航天装备 的权重合计超过67%。其前十大重仓股包括航发动力、中航沈飞、中航成飞等央企龙头企业，既具备核 心资产的稳定性，又拥有中小市值的成长弹性。 消息面上，据第一财经，GPU赛道之后，商业航天赛道也诞生了上市首日市值突破千亿的"新贵"。2月 10日，电科蓝天正式登陆科创板，当日开盘暴涨750.05%，收盘报65.94元，涨幅达596.3%，总市值达 1145亿元，成为2026年资本市场开年最受瞩目的新股。 中信建投证券指出，2026年商业航天方面，可复用火箭成产业化核心引擎：深蓝航天星云一号、天兵科 技天龙三号等密集验证回收技术，蓝箭航 ...

Group 1 - The Hang Seng Index decreased by 0.03% as of February 11, while the Hang Seng Stock Connect China Technology Index (HSSCT.HK) increased by 0.24%, with notable gains in stocks such as SenseTime-W (up over 6%), Bilibili-W (up over 4%), and Dongfang Zhenxuan (up over 3%) [1] - The Hong Kong Technology 30 ETF (513160) saw a slight increase of 0.25% with a trading volume of 45.2016 million yuan, and it has experienced net inflows for two consecutive trading days, accumulating over 360 million yuan in the past five days [1] - The ETF closely tracks the Hang Seng Stock Connect China Technology Index, which includes mainland companies engaged in technology business and listed in Hong Kong, with top holdings including SMIC, Meituan-W, Tencent Holdings, Alibaba-W, and Xiaomi Group-W [1] Group 2 - Alibaba's DAMO Academy released the RynnBrain model, which introduces spatiotemporal memory and spatial reasoning capabilities, significantly enhancing the intelligence level of robots and setting new records in 16 embodied open-source evaluation benchmarks [2] - Guohai Securities noted that user traffic in the internet industry is stabilizing, with leading companies shifting their strategic focus towards high-quality growth, and generative AI becoming a new driving force for valuation reshaping [2] - The market is expected to show strong index performance with structural differentiation and increased concentration among leading companies, particularly in technology businesses and profit realization [2]

2月10日，三大指数涨跌不一，创新药板块表现强势。截至当日收盘，恒生沪深港创新药精选50指数 (HSSSHID.HK)上涨2.26%收获六连阳，该指数成分股中，信立泰上涨近7%，石药集团与荣昌生物 （A）上涨超5%，信达生物上涨近5%。 海通国际证券指出，港股医药板块经历前期连续调整后，市场情绪有所回暖。随着港股业绩期临近，我 们看好业绩确定性强的互联网医疗、CXO/科研服务龙头。此外，我们建议持续关注本轮调整中回调幅 度较大的优质创新药龙头企业。 相关ETF方面，wind金融终端显示，截至当日收盘，创新药ETF天弘（517380）成交额超3700万元。资 金流向方面，截至2月9日，该ETF已连续3个交易日获资金净流入，累计净流入额为4166.12万元。该 ETF最新流通份额为25.04亿份，最新流通规模为19.63亿元。此外，生物医药ETF（159859）当日成交 额超1亿元，居同标的产品第一。该ETF最新流通份额为95.96亿份，最新流通规模为37.96亿元。 （文章来源：21世纪经济报道） 创新药ETF天弘（517380）为全市场唯一一只跟踪恒生沪港深创新药精选50指数的ETF，汇聚中国硬核 创新药力量 ...

有色ETF银华（159871）紧密跟踪中证有色金属指数（930708.CSI），中证有色金属指数选取涉及有色 金属采选、有色金属冶炼与加工业务的上市公司作为样本，以反映有色金属类相关上市公司的整体表 现。 消息面上，据智通财经，零售"零增速"震惊华尔街，美联储年内降息预期迅速升温。美国商务部人口普 查局周二公布的数据显示，去年12月零售销售额与去年同期持平，大幅不及预期的上升0.4%，亦低于 11月0.6%的增速。美国商务部还下调了去年10月份的零售销售数据，表明在生活成本上升的挑战下， 美国消费者出现了疲态，部分原因归咎于进口关税导致的物价上涨。业内人士表示，"零售销售数据让 市场对在非农就业数据公布前做空（美债）更感不安。关键在于劳动力市场疲软是否足以重燃对经济衰 退的担忧，并推动美联储在未来一年大举宽松。" 2月11日，三大指数涨跌不一，有色金属板块走强。中证有色金属指数(930708.CSI)上涨1.85%，该指数 成分股中，厦门钨业与博威合金上涨超5%，国城矿业上涨超4%，雅化集团与华友钴业上涨超3%。 国泰海通证券指出，关注企稳后的有色金属布局机会。市场风险偏好下行，贵金属价格调整。铜战略收 储预 ...

南方财经2月11日电，江苏新能(603693.SH)2月11日发布公告，公司拟向不特定对象发行可转换公司债 券，募集资金总额不超过12.4亿元。扣除发行费用后，募集资金净额将用于投资"连云港青口盐场渔光 一体化发电项目"和补充流动资金。其中，上述项目拟投入8.7亿元，项目总投资额为11.16亿元；另拟使 用3.7亿元补充流动资金。财务数据显示，2022年至2024年及2025年1-9月，公司分别实现营业收入19.71 亿元、19.46亿元、20.99亿元和15.26亿元；实现归属于母公司股东的净利润4.76亿元、4.72亿元、4.17亿 元和3.90亿元，营收与利润规模总体保持稳定。截至2025年9月30日，公司总资产为178.70亿元，合并资 产负债率为53.69%。此外，公司于2021年通过发行股份购买资产的方式，以7.5亿元对价收购了大唐国 信滨海海上风力发电有限公司40%的股权。收购资金已全额使用，相关标的资产已完成过户，在2021年 至2023年的业绩承诺期内，大唐滨海实现的扣除非经常性损益后的净利润分别为3.99亿元、2.88亿元和 2.87亿元，完成率均超过100%，全面达成业绩承诺。2025年 ...

南方2月11日电，有色·钨概念反复活跃，翔鹭钨业逼近涨停，章源钨业、中钨高新、厦门钨业跟涨。 消息面上，2月5日，章源钨业发布2026年2月上半月长单采购报价，55%黑钨精矿长单采购报价为67.00 万元/标吨，环比上行28.1%；55%白钨精矿长单采购报价为66.90万元/标吨，环比上行28.2%；仲钨酸铵 （国标零级）长单采购报价为97.00万元/吨，环比上行27.6%。 华源证券表示，近两周，黑钨精矿价格上涨25.19%至67.10万元/吨，仲钨酸铵价格上涨24.68%至98.50万 元/吨。供给端，矿山安全管控、环保管控趋于严格，部分矿山年尾开工及出货均呈现下降状态，钨矿 阶段性供应紧张明显。需求端，国内需求基本保持稳定，刚需采购为主，PCB刀具需求景气。近期，矿 山保守生产，市场增量预期弱，部分企业一月长单价进一步上调。建议关注：中钨高新、厦门钨业、翔 鹭钨业、章源钨业。 ...

南方财经2月11日电，百大集团(600865.SH)公告，公司于2026年1月21日收到上海证券交易所下发的 《关于百大集团股份有限公司业绩预告相关事项的监管工作函》，针对报告期内公允价值变动损失较大 的情况作出回复。百大集团：回复《问询函》关于对杭工信投资情况当中回复《问询函》关于对杭工信 投资情况。根据公告，公司预计2025年确认对杭工信的公允价值变动收益约-9440万元。截至2025年未 经审计期末，杭工信资产合计390,435.90万元，负债合计130,484.82万元，归属于母公司所有者权益 259,951.08万元，营业收入-22,486.34万元，净利润-94,704.96万元。2023年至2025年，公司对杭工信确 认的公允价值变动损益分别为-1,132.14万元、-3,743.03万元、-9,436.33万元，对应期末账面价值分别为 29,458.80万元、25,715.77万元、16,279.44万元。公司表示，杭工信股权无活跃市场报价，亦无再融资价 格，因此以持股比例享有的净资产作为公允价值估计基础，计算公允价值变动损益。百大集团：回复 《问询函》关于以公允价值计量的金融资产当中回复《问 ...

Core Viewpoint - The company Xinhan New Materials (301076.SZ) plans to raise up to 1 billion yuan through a private placement of A-shares to invest in three major projects, aiming to enhance its competitiveness in the specialty engineering plastics industry [1] Group 1: Fundraising and Investment Plans - The company intends to allocate 702 million yuan for an annual production of 8,100 tons of high-performance resin and composite materials [1] - An investment of 254 million yuan is planned for an annual production of 5,000 tons of monomer projects [1] - The remaining 44 million yuan will be directed towards establishing a high-performance composite materials innovation center [1] Group 2: Financial Performance - For the period from January to September 2025, the company reported a net profit attributable to shareholders of 51.53 million yuan, with a non-recurring net profit of 42.40 million yuan [1] - The company has distributed a total cash dividend of 95.72 million yuan from 2022 to 2024, representing 112.06% of the average distributable profit over the past three years [1] Group 3: Project Updates and Challenges - As of September 30, 2025, the company has invested 468 million yuan in fundraising projects, accounting for 84.36% of the net amount raised [1] - The annual production project of 8,000 tons of aromatic ketone has seen an actual investment of 334 million yuan, with the main construction completed but equipment installation delayed until June 30, 2026 [1] - The aromatic ketone project has generated cumulative benefits of 60.81 million yuan as of September 30, 2025, falling short of expectations due to project delays, high fixed costs, and intensified market competition [1]